BBI
BIIB icon

Baxter Bros Inc’s Biogen BIIB Stock Holding History

Baxter Bros Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,170
Closed -$1.17M – 119
2021
Q1 		$1.17M Sell
4,170
-1,680
-29% -$453K 0.2% 66
2020
Q4 		$1.43M Sell
5,850
-210
-3% -$54.2K 0.27% 62
2020
Q3 		$1.72M Buy
6,060
+983
+19% +$274K 0.37% 52
2020
Q2 		$1.36M Sell
5,077
-138
-3% -$41.5K 0.32% 55
2020
Q1 		$1.65M Buy
5,215
+1,361
+35% +$413K 0.43% 50
2019
Q4 		$1.14M Buy
3,854
+2,910
+308% +$807K 0.24% 63
2019
Q3 		$220K Sell
944
-50
-5% -$11.6K 0.05% 105
2019
Q2 		$232K Sell
994
-145
-13% -$33.5K 0.05% 105
2019
Q1 		$269K Buy
1,139
+110
+11% +$34.6K 0.06% 98
2018
Q4 		$310K Buy
1,029
+55
+6% +$17.6K 0.08% 95
2018
Q3 		$344K Sell
974
-28
-3% -$9.64K 0.08% 96
2018
Q2 		$291K Buy
1,002
+28
+3% +$7.87K 0.08% 98
2018
Q1 		$267K Sell
974
-78
-7% -$24.2K 0.07% 103
2017
Q4 		$335K Hold
1,052
– – 0.09% 98
2017
Q3 		$329K Hold
1,052
– – 0.09% 96
2017
Q2 		$285K Sell
1,052
-100
-9% -$26.4K 0.09% 97
2017
Q1 		$315K Sell
1,152
-191
-14% -$54K 0.1% 94
2016
Q4 		$381K Sell
1,343
-130
-9% -$38.5K 0.12% 89
2016
Q3 		$461K Sell
1,473
-145
-9% -$42.9K 0.16% 84
2016
Q2 		$391K Buy
+1,618
New +$426K 0.14% 89
2015
Q4 		$778K Buy
+2,539
New +$730K 0.29% 65

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Baxter Bros Inc's BIIB Position: Q2 2021 in Review

Baxter Bros Inc sold out of Biogen (BIIB) in Q2 2021, closing a stake of 4,170 shares — an estimated $1.17M sold.

Baxter Bros Inc first reported a position in BIIB in Q4 2015 and held it in 21 quarters. The position peaked at $1.72M in Q3 2020. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

  • Baxter Bros Inc reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
  • Baxter Bros Inc sold 4,170 Biogen shares in Q2 2021, an estimated $1.17M.
  • Baxter Bros Inc first reported a position in Biogen in Q4 2015 and held it in 21 quarters.
  • Baxter Bros Inc's Biogen position peaked at $1.72M in Q3 2020.
  • 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Baxter Bros Inc's 13F filing for Q2 2021, filed 11 Aug 2021.